Market Signal Briefing

Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF) vice president of exploration Greg Hahn talked with Proactive about new findings of high-grade antimony at the company’s Silverton project in Nevada.

Hahn said recent sampling returned values of up to almost 8% antimony and highlighted that the metal’s price has risen tenfold in a year due to China cutting off supply to the United States.

Proactive: Welcome back inside our Proactive newsroom. Joining me now is the Vice President of Exploration for Arizona Gold and Silver, Greg Hahn. Greg, it’s great to see you again. How are you?

Greg Hahn: I’m fine. Thanks for having me on.

Exciting news from the company about some new results — and this time, it’s not about gold or silver, but antimony. That’s an important critical metal these days. Give us your thoughts on antimony and where you see the price going.

Antimony is hot — you’re right. A year ago it was one-tenth of the price it is now, so it’s increased tenfold. That’s because China has cut off supply to the United States, and there’s now big demand for domestic production. It’s used mainly for armaments and defence purposes, so there’s a rush to find U.S. sources.

Silverton is where you’ve been looking for it. What are you seeing there?

Silverton is actually a large Carlin-type target, with strong arsenic, antimony, mercury, and thallium anomalies. It’s always had good antimony values, but it wasn’t a focus until the price jumped. We inherited a lot of samples that ran over 1% antimony — and when we re-sampled those areas, we found up to almost 8%. It’s pretty hot stuff locally.

Your main focus remains the Philadelphia project, but with these results, how do you balance both?

It’s something we’ll have to weave into our schedule. The good thing is, getting a permit from the Bureau of Land Management in Nevada was easy — it took about three weeks. We already had a permit on another part of the property, so we just moved it to the antimony target and adjusted the bond. We’re ready to go; it’s just about scheduling and budgeting.

What will that exploration program look like?

We’ve permitted 27 shallow drill holes to test the outcrops carrying antimony. It’s about a half-million-dollar program that we can fit in when the timing’s right. For now, we’re focused on Philadelphia, but Silverton is ready when we are.

And accessibility — is it easy to get to?

Yes, it’s almost a stone’s throw from U.S. Highway 6. Very easy access, open in several directions, and we’re looking forward to drilling it when the time comes.

Great update, Greg. I know Philadelphia remains the main target, but this is something worth watching.

It is. We’ll have to pay attention to it. At Philadelphia, we have a rig scheduled to arrive next week, so we’re excited for that as well.

Quotes have been lightly edited for clarity and style

October 11, 2025 10:00 ET

 | Source:

Nasdaq, Inc.

NEW YORK, Oct. 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in QMMM Holdings Limited for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in QMMM from 04:00:00 on September 29, 2025 to 23:59:00 on October 10, 2025. The last sale price of the company’s ordinary shares was $119.40. 

More information about the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104113.pdf.

Trading will remain halted until QMMM Holdings Limited has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Media Contact:

Michelle Mendiola
[email protected]

NDAQO

Top Canadian Weed Stocks to Watch Now as U.S. Reform Approaches
The Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a potential shift toward federal reform. This news lifted optimism across the industry, especially for Canadian producers eyeing future U.S. market entry. Currently, the U.S. cannabis market generates over $35 billion in annual sales and is projected to surpass $57 billion by 2030. Canadian companies are strategically positioning themselves to benefit from this growth through cross-border partnerships and product innovation. Moreover, many are expanding into wellness, beverages, and medical research to diversify revenue streams. As legalization efforts accelerate, Canadian cannabis firms could see renewed investor interest and significant upside potential in 2025.

However, navigating this volatile market requires precision and discipline. Traders should rely on technical analysis to identify key support and resistance levels before entering positions. Volume trends and moving averages often reveal momentum shifts early. Additionally, setting stop losses and taking profits at predetermined targets helps protect capital from sharp pullbacks. While cannabis stocks can deliver substantial gains, their price swings are often extreme. Therefore, proper risk management remains crucial for long-term success. Investors should scale positions carefully, monitor sector news, and adjust strategies as price action evolves. By combining sound analysis with patience and discipline, traders can manage volatility and capture opportunities in this fast-developing industry.

[Read More] 3 Cannabis REITs Leading the Marijuana Stock Market in October 2025

October 2025 Cannabis Stock Watchlist: Top Canadian Companies Positioned for Expansion

Tilray Brands, Inc. (NASDAQ: TLRY)
Canopy Growth Corporation (NASDAQ: CGC)
Village Farms International, Inc. (NASDAQ: VFF)

Tilray Brands, Inc. (TLRY)
Tilray Brands is a global cannabis, beverage, and wellness company with a rapidly growing U.S. presence. Its operations span hemp-derived products, THC-infused beverages, and medical cannabis. Tilray has expanded its reach through acquisitions in the beverage and wellness industries, positioning itself for long-term growth. The company’s U.S. strategy includes distribution across more than 1,000 retail outlets, with products ranging from CBD beverages to infused wellness items. In Canada, Tilray maintains a strong foothold as one of the top producers, while also expanding across Europe and Latin America. Its diversified business model gives it a unique advantage as legalization progresses in North America. Additionally, the company continues to strengthen its brand portfolio and explore new product categories, reinforcing its position as one of the most dynamic players in the cannabis sector.

Financially, Tilray reported net revenue of approximately $186 million in its most recent quarter, showcasing steady demand across its core business segments. Its beverage and wellness divisions outperformed expectations, helping offset slower growth in traditional cannabis sales. Gross margins improved year-over-year, reflecting better cost management and product mix optimization. The company also reduced operational expenses, aiming to reach profitability in the near term. Despite ongoing market headwinds, Tilray remains focused on global expansion and operational efficiency. Its balance sheet shows improved liquidity, and management continues to prioritize sustainable growth. With cannabis reform gaining traction in the U.S., Tilray could be well-positioned to capitalize on federal changes. Investors should monitor its technical levels around recent support zones, as bullish momentum could strengthen if legalization headlines accelerate.

[Read More] 3 Top Marijuana Stocks For Investors Who Like Long-Term Plays

Canopy Growth Corporation (CGC)
Canopy Growth stands as one of Canada’s most established cannabis companies, known for its wide range of products and international reach. The company operates leading brands in flower, edibles, and medical cannabis, while also maintaining a growing presence in the U.S. through partnerships with Jetty Extracts and Wana Brands. These affiliations give Canopy indirect access to several U.S. markets, preparing it for eventual federal legalization. In Canada, it continues to dominate the medical and recreational spaces with a broad retail footprint and advanced cultivation facilities. Additionally, Canopy has been restructuring operations to enhance efficiency and focus on profitability, closing non-core facilities to streamline production. Its strategy emphasizes brand leadership, medical research, and expansion into global markets such as Europe and Australia.

Canopy Growth’s most recent financial report showed modest revenue growth, supported by higher medical cannabis sales and improved pricing. The company achieved strong results in cost reduction, trimming total debt by nearly half over the past fiscal year. Its focus on restructuring has led to lower operating expenses, which could help accelerate profitability. The adult-use cannabis segment in Canada grew steadily, reflecting improved product distribution and customer retention. However, challenges remain, including pricing pressure and regulatory uncertainty in the U.S. Canopy continues to maintain a strong balance sheet relative to peers, providing flexibility for future investments. As U.S. legalization progresses, its partnerships and brand strength may drive long-term expansion. Traders watching CGC should look for potential breakouts above recent resistance, supported by increasing volume and momentum indicators.

[Read More] Top Marijuana Stocks for October 2025: U.S. MSOs Showing Strength and Growth Potential

Village Farms International, Inc. (VFF)
Village Farms International represents a successful transformation story within the cannabis sector. Originally a large-scale produce company, Village Farms pivoted into cannabis by leveraging its greenhouse expertise. The company’s Canadian subsidiary, Pure Sunfarms, is recognized for its efficient production and competitive pricing. In the U.S., Village Farms operates Balanced Health Botanicals, a hemp and CBD wellness brand that reaches consumers nationwide. The company also owns significant agricultural assets in Texas, which could become valuable if federal cannabis legalization occurs. Beyond North America, Village Farms expanded into Europe through its Leli Holland division, which now supplies legal cannabis to Dutch coffee shops under the Netherlands’ pilot program. This international diversification gives the company exposure to both emerging and mature cannabis markets, reducing overall risk.

Financially, Village Farms reported strong quarterly performance with revenue rising nearly 12% year-over-year to approximately $60 million. Net income surged, marking a return to profitability after previous losses. Adjusted EBITDA margins improved substantially, driven by higher international cannabis sales and disciplined cost management. The sale of its produce division provided additional liquidity, enabling the company to focus entirely on its cannabis operations. Village Farms also strengthened its balance sheet through debt refinancing and maintained a solid cash position. As one of the few profitable cannabis firms, it stands out for its operational efficiency and global reach. Investors may find VFF attractive due to its improving fundamentals and long-term growth trajectory. From a technical perspective, continued strength above its key moving averages could indicate sustained investor confidence and potential for further upside momentum.

Growth Opportunities Ahead of U.S. Legalization
As October progresses, these three Canadian cannabis companies—Tilray, Canopy Growth, and Village Farms—remain key players to watch. Each offers unique advantages: Tilray’s diversification, Canopy’s global leadership, and Village Farms’ profitability. The broader sector outlook is improving as the U.S. moves closer to reform, and Canadian producers could benefit significantly. Still, traders must stay disciplined by analyzing technical setups, managing risk, and monitoring news catalysts closely. Volatility will likely persist, but the combination of technical insight and proper risk management can help investors capture the next wave of opportunity in the evolving cannabis industry.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | [email protected]

Upstart shares have nearly doubled in the past 24 months, but they have been volatile.

Because it carries a small market cap of $5 billion, Upstart (UPST -6.99%) might not get a lot of attention from the investment community. However, the business is working on expanding access to credit to more borrowers, a noble mission. It's more exciting that Upstart is leveraging the power of artificial intelligence (AI) to succeed.

Shares have been extremely volatile. While they have soared 93% in the past two years (as of Oct. 3), they currently trade 87% below their all-time high. There's a lot to think about when considering Upstart for your portfolio.

Is this fintech stock a millionaire maker? Investors might benefit by analyzing both the positive and negative arguments.

Upstart has massive upside in theory
Since its founding in 2012, Upstart has originated $48 billion worth of loans. That's a tiny fraction of lending activity. Partnering with more than 100 banks and credit unions, Upstart currently offers personal loans, auto refinance loans, and home equity lines of credit. These three markets combined have trillions of dollars in annual origination volume. This creates a massive total addressable market for Upstart to tackle.

By using AI, Upstart is looking to disrupt the FICO scoring model, as its model looks at 2,500 different variables about potential borrowers. Upstart's partners win because this system can analyze creditworthiness better, and at the same time control for defaults. This can lead to more loans being approved, which supports greater revenue potential. And over time, the AI model should improve.

Upstart posted a 102% year-over-year revenue gain in the second quarter (ended June 30). This figure was powered by a 159% jump in transaction volume. Should the Federal Reserve continue to lower interest rates, demand for loans can trend higher, and Upstart will then see greater activity on its platform.

Another obvious factor that introduces upside is Upstart's valuation. Investors can scoop up shares at a price-to-sales ratio of 5.8. Since the company's initial public offering in December 2020, the average multiple the stock sold for was 11.2. While not as cheap as three years ago, the valuation can go higher should the business report consistently strong financial performance.

Heightened uncertainty makes this a risky investment
Upstart might operate at the cutting edge of AI and machine learning, but the company's financial results have proven to be extremely cyclical. Instead of performing like a software enterprise that can seemingly grow in any economic environment, Upstart behaves like a traditional bank that's influenced by macro forces.

In this case, changes in interest rates have had a big impact. In 2021, Upstart's revenue skyrocketed 264% year over year, and the company raked in $135 million in generally accepted accounting principles (GAAP) net income. In 2024, revenue was 25% lower, and the business posted a $129 million net loss. Things appear to be improving, as mentioned, with huge growth reported in Q2. And the leadership team expects Upstart to be profitable this year, but not by much.

However, no one really knows how the company will perform over an entire credit cycle. Consequently, there is a considerable amount of uncertainty with Upstart's long-term success. If the business is able to get to a point that it can register solid growth and consistent earnings, even in difficult economic times, then investors can have a lot more confidence.

On the flip side, there is a very real risk of the impact a recession can have. Similarly to 2022, even though there wasn't an economic downturn that year, Upstart could face immense pressure as credit markets tighten up.

Since this is a mid-cap company that offers lending products in sizable end markets, the stock could work out extremely well should Upstart execute flawlessly and if the external environment is accommodating. But that outcome is far from a certainty, so investors should temper their expectations. Upstart is an exciting company. Owning the stock probably won't make you a millionaire, though.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Upstart. The Motley Fool has a disclosure policy.

Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveProfile SettingsCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Profile Settings

Recently Searched

ATAT2.46%

ATAT2.46%

Palantir Among Tech Leaders Elevated To Best Stock Lists: Check Out The IBD 50, IPO Leaders, Sector Leaders And More

ORCL1.35%

ORCL1.35%

Stock Market Week Ahead: Gridlock, Q3 Earnings And AI Conferences

Tariff Troubles Flare Up Again. Here's What To Do Now. CBOE, Casey's General Store, Cencora In Focus.

CrowdStrike (CRWD), Zscaler (ZS), Snowflake (SNOW), Oracle (ORCL) and Palantir (PLTR) make up this week's stocks to watch, all trading near buy points. All five software makers have stakes in the artificial intelligence field, whether it's cybersecurity, data analytics or defense projects. AI remains the hottest trade and it's helped these companies' sales and earnings flourish. Friday's market sell-off pushed…

The satellite radio operator is a Berkshire Hathaway holding.

Sirius XM (SIRI -5.65%) is a Berkshire Hathaway holding: The Warren Buffett conglomerate owns 37.1% of the company's outstanding shares, so the Oracle of Omaha might see something he likes about the company.

Berkshire's apparent endorsement, though, doesn't change the fact that Sirius XM's share price has dropped by 59% over the past five years. Its valuation is now quite cheap, at a forward price-to-earnings ratio of 7.4 -- which might pique the interest of some investors.

But is there a future for Sirius XM?

Image source: Getty Images.

Sirius XM is on the wrong side of a major tech trend
Sirius XM is the only satellite radio operator still in business. However, it has faced major headwinds thanks to the advent of high-performance smartphones and better internet connectivity. The company's subscriber base and revenue have not grown meaningfully for years.

Meanwhile, popular audio streaming services from Apple, Spotify, Alphabet, and others have achieved tremendous success. This isn't going to change.

It's smart for investors to put their money into businesses benefiting from secular trends. Technological shifts can provide a long-term boost to such companies' customer, revenue, and earnings growth.

Unfortunately, Sirius XM doesn't fall into this category. Yes, its shares are cheap, and it produces positive free cash flow, but the company faces a difficult road ahead. Would-be investors should proceed with caution.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Apple, Berkshire Hathaway, and Spotify Technology. The Motley Fool has a disclosure policy.

SummaryInterest rates are now declining.Small-cap highly leveraged REITs offer the most upside potential.I present 5 great options to consider in preparation for further rate cuts.High Yield Landlord members get exclusive access to our real-world portfolio. See all our investments here » phototechno/iStock via Getty Images

The big news of this past month was that the Fed cut interest rates for the first time since December 2024.

Not only that, but they strongly implied in their commentary that more rate cuts would

Analyst’s Disclosure:I/we have a beneficial long position in the shares of WSR; MAC; AHH; CLPR; HOM.U:CA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Earnings season is ready to kick off, but this company typically provides no surprises.

Coca-Cola (KO 1.02%) needs no introduction. It's a leader in its industry, has a presence in more than 200 countries and territories, and sells 200 different drinks. The company is a top position for Warren Buffett-led Berkshire Hathaway, highlighting its quality.

This is an extremely stable and predictable business, but that doesn't mean investors aren't interested in the latest financial figures that provide key insights into how Coca-Cola is performing. Management plans to release third-quarter 2025 results on Oct. 21.

Should you buy this beverage stock before then?

 

 

This is a top choice for income investors
In my opinion, the only investors who should even consider buying this stock are those who want dividends. Coca-Cola pays a dividend yield of 3.08%, and it has increased the payout for an impressive 63 straight years.

In the past decade, shares have dramatically underperformed the S&P 500. The low-growth nature of the business doesn't bode well for big share gains.

Investors should expect no surprises
Coca-Cola faces steady demand, as people love its products even in weak economic periods. It also has a powerful brand that supports its pricing power. This drives robust profitability that funds the dividend.

These factors make Coca-Cola a solid company that rarely gives investors any surprises. This minimizes the effect of any single quarterly earnings report.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool has a disclosure policy.

This business proves that not all car makers are created equal.

Putting money to work in the auto industry isn't a smooth ride. These types of companies are generally very capital intensive, register low growth and profits, and face cyclical demand. The auto market is very competitive.

However, an opportunity exists to make money in this part of the economy. Here's one of the best automotive stocks to buy right now.

 

Ferrari is a luxury brand masquerading as a car company
Ferrari (RACE -3.08%) isn't your average car company. What separates it from the pack is its incredible brand strength, which puts it in the same category as luxury fashion houses, as opposed to its direct peers in the auto industry. The leadership team emphasizes quality over quantity, with the goal of keeping supply well below demand. This supports Ferrari's impressive pricing power.

Between 2014 and 2024, revenue and net income increased 142% and 476%, respectively. Ferrari boasts a stellar 24% trailing-10-year average operating margin.

Shares deserve a premium valuation
Ferrari stock, which has climbed 771% (as of Oct. 8) since its initial public offering in October 2015, doesn't look like a bargain. Investors must be willing to pay for a price-to-earnings ratio of 49.4 to own the business. But given Ferrari's healthy sales and profit gains, coupled with its brand power, it's certainly not a stretch to believe the shares are deserving of a premium valuation.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool recommends Ferrari. The Motley Fool has a disclosure policy.

This stock has absolutely soared since the fall of 2022.

Since the company's growth and profitability took a hit in 2022, leading to the stock also tanking, Meta Platforms (META -3.85%) has been a winning investment. In the past three years, shares have skyrocketed 437% (as of Oct. 9). The business has been riding some serious momentum. Now, investors are patiently waiting for management to release financial results from the latest quarter.

Should you buy this social media stock before Oct. 29?

Meta stock looks like a good opportunity
Despite Meta's meteoric rise in the past three years, the current setup still looks favorable. The stock is trading 9% below its peak. Investors can scoop up shares at a compelling forward price-to-earnings ratio of 24.6.

For one of the most dominant enterprises in the world, this might be a no-brainer buying opportunity. This is especially true before a potential positive catalyst in the upcoming earnings report.

Investors must maintain a long-term mindset
Meta has exceeded Wall Street earnings per share estimates in 11 straight quarters. Perhaps it's likely this streak will continue, which could push the stock higher as we head into November.

As enticing as it sounds to buy shares before the Oct. 29 update, it's extremely important that investors aren't making this decision with a short-term mindset. Buying and holding stocks should be done with a timeframe that spans at least five years, forcing investors to think about the fundamentals.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool has a disclosure policy.

SummarySoleno Therapeutics is reassessed after a 24% drop post-VYKAT XR approval enthusiasm.SLNO now faces the critical 'danger zone' between FDA approval and successful commercialization of VYKAT XR for Prader-Willi syndrome.The company's hefty market cap and total reliance on VYKAT XR put it in 'show me' mode for investors.Previously rated as 'Hold,' SLNO's future prospects depend on its ability to execute post-approval commercialization.Its prospects are favorable given its strong liquidity and its competitive situation in a compelling indication. Wylius/iStock via Getty Images

This is my third Soleno Therapeutics (NASDAQ:SLNO) article, following 06/2025's "Soleno Therapeutics: Overbought On VYKAT Approval Enthusiasm". In Overbought, I rated Soleno as a "Hold". It has since dropped ~24%. I am taking another look to see

Analyst’s Disclosure:I/we have a beneficial long position in the shares of RYTM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I may buy shares in Soleno over the next 72 hours or buy or sell shares in other mentioned companies over the next 72 ours.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About SLNO Stock

More on SLNO

Related Stocks

SLNO

-

Trending Analysis

Trending News

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

So what: If you purchased KBR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) despite the knowledge that the U.S. Department of Defense's Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe's ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants' statements about KBR's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. 

To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

IonQ is one of the most popular quantum computing stock picks.

Turning $10,000 into $1 million is no easy feat. It requires a relatively small company that's offering a solution for a wide-ranging problem to capture nearly all of the market share. One of the best recent examples is Nvidia (NVDA -4.84%), which turned a $10,000 investment a decade ago into more than $3 million.

Unfortunately, investors don't have a time machine to go back and buy shares of this massive winner before the jump. Still, we can examine what made Nvidia a winning stock pick and apply those observations to another stock. One area that has similar potential to Nvidia is quantum computing. There is obvious overlap here, as Nvidia's graphics processing units (GPUs) are the most powerful classical computing units available. With the massive demand for AI computing power, Nvidia experienced monstrous growth.

However, if a viable quantum computing technology is developed, these GPUs could be replaced by quantum computing units, causing a quantum computing pureplay like IonQ (IONQ -8.53%) to exhibit a similar rise over the next decade.

So, can IonQ turn a $10,000 investment into $1 million? Let's take a look.

Image source: Getty Images.

IonQ's computing accuracy is far better than its peers
IonQ's approach to quantum computing is different than its peers. Instead of the typical superconducting approach, which requires cooling the particle down to near absolute zero, IonQ uses trapped ion technology. The trapped ion approach allows for quantum computing calculations to be done at room temperature, reducing input costs. Additionally, trapped ion computing is inherently more accurate than superconducting quantum computing, and this is apparent in IonQ's world records.

IonQ holds world records in quantum computing accuracy in both one-qubit and two-qubit gate fidelity tests, a measure of how accurate a quantum computer is after a computing process occurs. IonQ's two-qubit gate fidelity is 99.97%, which is significantly higher than other quantum computing companies like Rigetti Computing, which has a 99.5% fidelity in two-qubit gates.

This advantage isn't without its drawbacks. The trapped ion approach has slower processing speeds than superconducting quantum computers, which makes the technology less desirable if the two technologies can achieve similar accuracy levels.

However, if IonQ can develop a commercially viable computer and establish a foothold in the industry faster than its competitors, it will be a significant achievement. Then it may have just enough of a first-mover advantage to win the quantum computing race. There's no guarantee of this, which makes IonQ a risky stock pick.

But if it does, is there enough of a market to provide 100x returns?

IonQ has the potential for massive returns
Right now, IonQ has a market cap of around $20 billion. That means IonQ would be a $2 trillion company if it delivered 100x returns. That would be an incredible rise and would rank IonQ among the largest big tech companies, but is that realistic?

IonQ believes the total addressable market for quantum computing will be around $87 billion by 2035. For reference, Broadcom (AVGO -5.90%), which is worth $1.6 trillion, projects to generate around $63.3 billion in sales this fiscal year.

However, IonQ's projection isn't an annual value, so investors need to decrease their expectations. Rigetti Computing offers another market projection, where it believes the annual value for quantum computing providers will be around $15 billion to $30 billion between 2030 and 2040.

If IonQ could capture 100% of the market share ($30 billion in annual revenue), achieve 50% profit margins (similar to Nvidia's), and attain a 50 times earnings multiple (similar to Nvidia's), that would value the stock at $750 billion, well short of the $2 trillion needed to make the stock a 100-bagger. So, if we draw up the best-case scenario for IonQ, it likely won't be enough to achieve the 100x returns we're looking for.

However, this doesn't mean IonQ is a bad investment. Investors just need to adjust their expectations for this quantum computing stock. Furthermore, there are no guarantees that IonQ will have a winning quantum computing approach, and the stock could go to zero if a different company wins the quantum computing arms race. This makes IonQ a high-risk, high-reward stock.

As a result, investors should keep their position sizes relatively small; that way, if it flops, it won't be a big hit to their portfolio. But, if it hits it big and captures a large part of the market, it can still provide impressive returns; just don't expect it to make you a millionaire.

Keithen Drury has positions in Broadcom and Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.

Some elements of Firefly's deal to buy SciTec are inarguably weird -- but overall, it's a great deal for Firefly.

How much is Firefly Aerospace (FLY -5.39%) stock worth?

At Tuesday's close, shares of Firefly, builder of the Alfa rocket and the second American company to land on the moon in the last 50 years, cost $28 and change. This was down marginally from Monday, but up a bit from last week, when this rocket stock touched a lowest-ever-since the IPO price barely above $26.

Firefly Blue Ghost casts a shadow on the moon. Image source: Firefly Aerospace.

Some Wall Street analysts think Firefly stock is worth a lot more than that. Deutsche Bank, for example, recently posited a $40 price for Firefly. And over the weekend, I received an email from analysts at Cantor Fitzgerald, confidently assuring me that Firefly can hit $65 within a year!

And then there's SciTec -- the defense company that Firefly just announced it intends to buy. Some way, somehow, Firefly has convinced SciTec to value Firefly stock at $50, and now SciTec is taking that stock in payment as it sells itself to Firefly.

Some in cash, some in stock
As Firefly described its offer to acquire SciTec over the weekend, it intends to pay the smaller part of its $855 million purchase price ($300 million) in cash. The larger part of its payment, however, will take the form of 11.1 million Firefly shares handed over in exchange for SciTec.

And each one of those shares will be valued at $50.

The art of the deal at Firefly
The value of any stock lies largely in the eye of the beholder, of course. That's why on any given day, one investor will happily sell a stock for $X and think she got a good price, while another investor will be just as happy to buy the stock for $X -- and also count himself lucky!

That doesn't make it any less weird, though, to see SciTec agree to value Firefly shares, tendered in payment for SciTec, at nearly twice the market price of identical Firefly shares already trading on the Nasdaq.

How did this come about? I can only imagine that Firefly initially approached SciTec, and secured its agreement to a buyout, sometime in mid-August, shortly after the Firefly IPO, when Firefly stock was still trading near $50. The financial terms were agreed to, SciTec signed on the dotted line, and Firefly required SciTec to keep the terms of the deal it originally struck when the acquisition was finally announced this month.

That's my theory, at least.

How great of a deal did Firefly get?
Whether I'm right about how the price got set though, or wrong, the fact of the matter remains: Firefly got a great deal on SciTec.

As Firefly noted in its press release announcing the acquisition, SciTec is a specialist in "mission software, rapid data processing, and low-latency AI systems that support missile warning, tracking, and multidomain operations." It's a defense contractor, in other words, specifically a defense contractor that owns a lot of technology that could be useful when bidding on contracts to build President Trump's Golden Dome missile defense system.

Firefly CEO explained that buying SciTec, therefore, "enhances our ability to support a growing number of defense missions and provides us with a significant operational advantage," especially when competing for Golden Dome contracts.

The deal also diversifies Firefly's revenue stream. No longer a start-up of a space stock with barely $100 million in annual revenue, buying SciTec and its $164 million annual revenue stream will transform Firefly into a more equally weighted 60/40 defense/space business. It will also more than double the company's total annual revenue stream to more than $260 million.

And at Firefly's current market capitalization of $3.9 billion, it will also give Firefly a much more reasonable-looking price-to-sales ratio of about 15. That's still not cheap for a space stock, exactly. (Historically, 4x sales has been a more common valuation for unprofitable space stocks.) But it's a lot cheap-er than when Firefly is valued on its pre-SciTec revenue -- costing roughly 39 times trailing sales.

A steal of a deal
Speaking of price to sales valuations, I can't fail to mention the bargain price Firefly is getting for SciTec. Valued -- as I just mentioned -- at 39x sales itself, Firefly is paying a mere 5.2x trailing sales for SciTec.

Say what you like about the excessive valuation of Firefly's own stock today, but the company's making smart use of its richly valued stock to snap up a much cheaper subsidiary at a bargain price, and dramatically grow its revenue stream in the process.

Firefly shareholders should applaud the move.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Key Takeaways
JPMorgan analysts this week suggested a long list of ideas for bets that some stocks will fall.The suggestions covered companies ranging from restaurants to airlines, dating apps and tech.

With stocks not far from their recent highs, are you looking to bet on which ones might fall? 

Some investors look to profit from share prices they consider elevated by making short bets, borrowing shares to sell that they then seek to repurchase when they’re less expensive, pocketing the difference.

Earlier this week, JPMorgan asked its analysts to pick their favorite short ideas headed into the start of the fourth quarter. They handed back a list of 27 stocks, which included those of a major airline and a burger chain. Here are summaries of a few of those picks. 

Why This Matters to Investors
Short-selling is a possible tactic for investors who think stocks are more likely to fall than rise. A recent collection of short ideas from analysts at JPMorgan shows that those ideas can be inspired by a range of companies—and reasons.

Southwest Airlines (LUV): The stock is down about 7% this year through Friday’s close, compared to the S&P 500's roughly 12% climb. 

The airline, JPMorgan wrote, is in the early innings of a transformative shift away from its core long-standing brand” and has issued “ambitious” fourth-quarter guidance. Demand trends are promising, the analysts wrote, but they were also concerned about the stock’s valuation. 

Visible Alpha’s mean price target, around $31, would suggest little change from Friday’s close. 

Shake Shack (SHAK): The burger chain’s shares have lost about a third of their value this year.

JPMorgan raised questions about high menu prices that could limit its growth opportunity, possibly shrinking both its addressable market and the frequency with which people visit.

Visible Alpha’s average price target, at $133, would suggest an over 50% gain from Friday’s close near $87. 

Bumble (BMBL): Shares of the digital dating company have fallen nearly 40% in 2025.

JP Morgan analysts worried about declines in the use of the Bumble app and the possibility that marketing expenditures will hurt margins.

The mean price target of analysts tracked by Visible Alpha is about $7, up $2 or 40% from Friday’s close. 

Rivian (RIVN): The EV maker’s stock is down close to 4% this year.

JPMorgan expects the recent expiration of federal EV tax credits to weigh on demand, with changes associated with President Donald Trump’s “One Big Beautiful Bill” seen as hitting its ability to sell profitable regulatory credits to other automakers, pressing overall margins.

Visible Alpha's mean price target on Rivian's shares is around $14, a 9% rise from yesterday's close.

Other picks shared by the bank’s analysts included Krispy Kreme (DNUT), which it said was pressed by balance-sheet issues that would hamper its turnaround; insurance company Travelers (TRV), which it said was facing “overly optimistic” consensus estimates; Snapchat operator Snap (SNAP), which it said would struggle to compete for business with social platforms that use AI more effectively; and self-driving auto systems company Mobileye Global (MBLY), which it said had a “premium valuation” unsupported by its revenue growth expectations.

Do you have a news tip for Investopedia reporters? Please email us at

[email protected]

SummaryMarathon Digital operates 1.1 GW of owned power capacity at $0.04/kWh, positioning it as a low-cost AI infrastructure play.The EDF Exaion acquisition gives MARA access to Tier-4, GDPR-compliant AI data centers and European enterprise clients.IREN re-rated on visible GPU contracts, while MARA awaits AI revenue from Exaion and TAE Power integration.Despite record Q2 results, $238.5M revenue, $1.2B EBITDA, $808M net income, MARA trades at only ~9x EV/EBITDA.Successful AI monetization could double MARA’s valuation, closing its 53% discount to peers trading near 20x EV/EBITDA. PhonlamaiPhoto/iStock via Getty Images

Investment Thesis Since my previous coverage, Marathon (NASDAQ:MARA) is up by 32%, but it only trades at ~9x EV/EBITDA, well below peers. The market only sees it as a pure Bitcoin (

Analyst’s Disclosure:I/we have a beneficial long position in the shares of MARA, CLSK, NVDA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Investors might struggle to find better-performing stocks than this AI leader.

When the topic of artificial intelligence (AI) comes up, Nvidia (NVDA -4.84%) is probably the first company that comes to mind. The prosperous technology enterprise is helping to build out AI infrastructure across the globe. Shareholders who have been along for the ride should have zero complaints.

If you bought $500 worth of this thriving AI stock five years ago, here's how much money you'd have today.

Investors have reaped massive rewards from this AI stock
Over the past five years, Nvidia shares would've turned a $500 investment into an unbelievable $6,800 today (as of Oct. 7). That's a 1,250% total return. Nvidia is now the most valuable business on Earth, with a colossal market cap of $4.5 trillion.

Nvidia is the top winner in the AI boom
It seems that companies have no desire to let up on the gas pedal, as they are investing copious amounts of capital in AI-related infrastructure. Nvidia has been a direct beneficiary; its customers have insatiable demand for its data center graphics processing units. Nvidia's revenue totaled $46.7 billion in its fiscal 2026 second quarter (ended July 27). This was a monster increase of 618% compared to exactly five years ago.

Wall Street analysts believe the top line will grow 149% between fiscal 2025 and fiscal 2028. That's an exciting outlook. However, if there's any sign of a slowdown in AI spending, Nvidia's stock might experience a rapid sell-off.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.

Apple's core iPhone business is doing well, but its long-term AI strategy is still a big unknown for investors.

Apple (AAPL -3.40%) is one of the world's biggest technology companies, yet the company has failed to significantly benefit from artificial intelligence (AI) in any meaningful way. That's more of a general consensus than a hot take on Apple. If you follow the company even loosely, you know that Apple's slow-and-steady approach to innovation has come under fire for years now.

And yet, Apple continues to make some of the best consumer technology products on the market. Its latest iPhone 17 lineup appears to be attracting significant interest, and revenue from its digital services is climbing higher.

While my crystal ball is permanently cloudy, here's where I think all of this could take Apple over the next year.

What's going well at Apple right now
Apple's underlying business is still driven by sales of the iPhone, and that's unlikely to change any time soon. iPhone sales rose by 13.5% in the third quarter to $44.5 billion as consumers rushed to buy devices on worries that tariffs could drive prices higher. Those sales helped boost total revenue by nearly 10% to $94 billion, the largest revenue growth for the company in four years.

More good news is likely on the way for the company and its investors, as initial demand for its new iPhone 17 lineup appears to be high. A Morgan Stanley estimate says "The iPhone 17 cycle is modestly stronger than we originally expected," and a J.P. Morgan Chase analyst said the iPhone 17 Pro has higher demand than the iPhone 16 Pro when it first launched.

Another positive is that Apple's management said on the third-quarter earnings call that it expects revenue to grow by mid- to high-single digits in the fourth quarter (which will likely be reported later this month).

What's more, the company continues to benefit from expanding services revenue. Apple services revenue rose by 13% to $27.4 billion in the quarter. Sales from its services -- which include its AppleCare products, AppleTV+, Apple Music, and Apple Fitness+, among others -- accounted for 29% of total sales in the second quarter. That's up from 25% two years ago.

Where Apple continues to fall short
Of course, Apple isn't without some significant concerns right now. Despite a seemingly successful iPhone launch, strong third-quarter results, and rising services revenue, the company still appears to be fumbling in the artificial intelligence space.

It's been a couple of years since Apple announced its Apple Intelligence features for its products, which have mostly failed to impress compared to advanced systems from Alphabet and OpenAI. Some AI features that were advertised in commercials two years ago still haven't been released, which was the subject of a recent lawsuit.

Apple has tried to catch up and has partnered with OpenAI to hand off more complex questions and tasks to ChatGPT when Siri can't handle them. But even with the iPhone 17 launch, there was little to show investors that Apple is pursuing AI with much gusto. CEO Tim Cook said on the third-quarter earnings call that Apple would consider making deals that could improve its AI position, saying, "We're very open to M&A that accelerates our road map."

Bloomberg also recently reported that Apple has developed an internal AI chatbot used by employees and is working on an AI-based search engine and a new version of Siri. But the estimated release for some of those services, if they ever see the light of day, isn't until 2027.

Where will Apple be in a year?
The next year feels pretty significant for Apple. The company has failed to make meaningful strides with its AI ambitions, and many investors have already lost their patience. Apple stock has failed to keep pace with the S&P 500 index over the past three years.

I'm personally giving the company a little more time before considering what to do with my Apple shares. I think the company could eventually release an improved Siri and other features that rely on an outside AI model -- from OpenAI or Anthropic -- that capture the attention of its users.

But I do think the next year may be another period of waiting for Apple investors as the company tries to find its AI footing.

JPMorgan Chase is an advertising partner of Motley Fool Money. Chris Neiger has positions in Apple. The Motley Fool has positions in and recommends Alphabet, Apple, and JPMorgan Chase. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Marvell Technology (MRVL -5.43%) stock has jumped more than 30% since I rated it a buy roughly one month ago.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Dividend exchange-traded funds have become a popular way to own a diverse set of stocks while generating steady, passive income.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of FANG, OXY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: I am not an investment advisor and this is not a recommendation to buy or sell a security. Investors are recommended to read all of the company's filings and press releases as well as do their own research to determine if the company fits their own investment objectives and risk portfolios.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

XRP crashed from $2.83 to $1.77 before rebounding to $2.44 — still down 14% in 24 hours but showing early signs of recovery.Exchange supply stayed flat through the drop, confirming a derivatives-led panic rather than spot-driven selling, as Wyckoff VSA shows liquidation pressure cooling.Whales added 1.04 billion XRP ($2.54 billion) during the crash, signaling accumulation at the bottom and supporting a potential rebound toward $2.74–$2.82.XRP price saw one of its sharpest drops of the year. It plunged from $2.83 to as low as $1.77 in a matter of hours before bouncing to around $2.44.

Even after that rebound, the token is still down about 14% in 24 hours and nearly 20% weekly. But the data shows this wasn’t a normal sell-off — it was a panic-led, derivatives-driven flush, not real token selling. And now that the XRP price rebound is shaping up, a key group is seen adding to the token stash.

Sponsored

Sponsored

Panic-Led Derivatives Crash, Not Spot SellingOn-chain data confirms that this was not a wave of investors dumping tokens.

Over the past month, XRP’s supply on exchanges has hardly moved, even through this violent drop, showing that few coins were sent to exchanges for sale.

XRP Supply On Exchanges: SantimentInstead, the slide possibly began in the derivatives market, where over-leveraged long positions got liquidated as prices broke key support levels. When that happens, exchanges automatically close futures contracts, triggering forced selling in order books — even though no tokens move on-chain.

Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

This off-chain panic shows up clearly in the Wyckoff Volume Spread Analysis (VSA): a huge red bar formed at the peak of the liquidation wave, followed by yellow bars as the selling eased.

XRP Price Fractal: TradingViewSponsored

Sponsored

That shift from red (full selling control) to yellow (weaker control) usually means forced liquidations are cooling down.

Wyckoff Volume Spread Analysis (VSA) tracks how price and volume interact to show when buying or selling pressure dominates. VSA doesn’t know where that volume comes from — it doesn’t distinguish between spot selling and derivative-driven liquidations.

The last time XRP’s Wyckoff bars showed a similar red-to-yellow transition in early May, the token rebounded over 54% from its lows. If this pattern repeats, a similar move could follow once the panic fades. And that puts the XRP price target of $2.74 in play.

Whales Accumulate as the Market CoolsWhile smaller traders were being flushed out, whales were quietly buying.

Sponsored

Sponsored

Data from Santiment shows that wallets holding more than 1 billion XRP increased their holdings from 23.98 billion to 25.02 billion after the crash — an addition of roughly 1.04 billion XRP, worth about $2.54 billion at the current XRP price.

That behavior aligns with the on-chain picture: no major spike in exchange balances and rising whale holdings mean this wasn’t spot selling — it was a derivatives panic met by whale accumulation.

XRP Whales Start Buying: SantimentNote: The stable exchange supply also fits the picture. Large holders usually buy through OTC deals or internal swaps. Hence, their accumulation doesn’t immediately show up as on-chain exchange outflows.

Such setups often mark the bottom phase of a sentiment-driven crash, where strong hands absorb weak hands before a recovery begins.

Sponsored

Sponsored

XRP Price Eyes “This Rebound Target” as Recovery BuildsAt press time, XRP trades at $2.44. This level aligns with the 0.5 Fibonacci level from the previous swing high to the $1.70 zone, the newest multi-week low.

If XRP manages a daily close above $2.43, the structure strengthens for a move toward $2.59. That could be followed by $2.82 (key resistance). That aligns with the Wyckoff projection of over $2.74, presented on the earlier chart.

XRP Price Analysis: TradingViewAn XRP price fall below $2.28, however, would weaken the setup and open downside risks to $2.05.

With whales accumulating, exchange supply stable, and panic liquidations easing, the data points to a clear shift in sentiment. This wasn’t real capitulation — it was a sentiment-driven washout that might have set the stage for XRP’s next short-term rebound.

Disclaimer

In line with the Trust Project guidelines, this price analysis article is for informational purposes only and should not be considered financial or investment advice. BeInCrypto is committed to accurate, unbiased reporting, but market conditions are subject to change without notice. Always conduct your own research and consult with a professional before making any financial decisions. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.